- Home
- HOOK vs ABTS Comparison
HOOK vs ABTS Comparison
Compare HOOK & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOOK
- ABTS
- Stock Information
- Founded
- HOOK 2011
- ABTS 2010
- Country
- HOOK United States
- ABTS Hong Kong
- Employees
- HOOK N/A
- ABTS N/A
- Industry
- HOOK Biotechnology: Pharmaceutical Preparations
- ABTS Computer Software: Programming Data Processing
- Sector
- HOOK Health Care
- ABTS Technology
- Exchange
- HOOK Nasdaq
- ABTS Nasdaq
- Market Cap
- HOOK 9.3M
- ABTS 4.6M
- IPO Year
- HOOK 2019
- ABTS N/A
- Fundamental
- Price
- HOOK $1.47
- ABTS $2.33
- Analyst Decision
- HOOK Buy
- ABTS
- Analyst Count
- HOOK 4
- ABTS 0
- Target Price
- HOOK $10.67
- ABTS N/A
- AVG Volume (30 Days)
- HOOK 134.3K
- ABTS 30.6K
- Earning Date
- HOOK 05-20-2025
- ABTS 12-31-2024
- Dividend Yield
- HOOK N/A
- ABTS N/A
- EPS Growth
- HOOK N/A
- ABTS N/A
- EPS
- HOOK N/A
- ABTS N/A
- Revenue
- HOOK $43,946,000.00
- ABTS $6,711,225.00
- Revenue This Year
- HOOK N/A
- ABTS N/A
- Revenue Next Year
- HOOK N/A
- ABTS N/A
- P/E Ratio
- HOOK N/A
- ABTS N/A
- Revenue Growth
- HOOK 118.32
- ABTS 299.11
- 52 Week Low
- HOOK $0.72
- ABTS $0.25
- 52 Week High
- HOOK $10.50
- ABTS $4.19
- Technical
- Relative Strength Index (RSI)
- HOOK 67.61
- ABTS 47.79
- Support Level
- HOOK $1.14
- ABTS $2.25
- Resistance Level
- HOOK $1.67
- ABTS $3.10
- Average True Range (ATR)
- HOOK 0.16
- ABTS 0.46
- MACD
- HOOK 0.10
- ABTS -0.02
- Stochastic Oscillator
- HOOK 78.69
- ABTS 35.04
About HOOK HOOKIPA Pharma Inc.
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in partnership with other companies. Its Hepatitis B (HBV) program, HB-400, and Human Immunodeficiency Virus (HIV) program, HB-500, are being developed in partnership with Gilead.
About ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations.